CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical

Login to View

China Capital Investment Group (CCIG), a subsidiary of CICC, has led a RMB700 million (US$102.67 million) series B round in Beijing Allcure Medical Technology Co. Ltd., which develops standardized tumor diagnosis and treatment centers.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in